Abbott EAS Sales Offset First Quarter Decline In Pediatric Nutritionals
This article was originally published in The Tan Sheet
Executive Summary
EAS has emerged as a strong contributor to Abbott's Ross adult nutritionals business
You may also be interested in...
North Castle sells Enzymatic Therapy to Nature’s Way
Springville, Utah-based herbal and natural product manufacturer Nature's Way acquires natural medicine and supplement firm Enzymatic Therapy under an Oct. 9 agreement with the North Castle Partners private equity firm, Enzymatic Therapy's majority shareholder. Green Bay, Wis.-based Enzymatic Therapy says Oct. 17 that all other shareholders approved the sale, which will close pending regulatory approvals. North Castle also was the majority investor in Naked Juice when PepsiCo acquired it in 2007 (1"The Tan Sheet" Nov. 27, 2007, In Brief). The Greenwich, Conn.-based firm also owned controlling interest in the EAS sports nutrition company when Abbott Labs acquired it in 2004, and it was part of the fund with majority investment when Leiner was sold in bankruptcy court (2"The Tan Sheet" April 18, 2005, p. 15 and 3"The Tan Sheet" June 9, 2008, p. 3)
Abbott Repatriation Could Fund Foreign Operation Building
Abbott is eyeing foreign expansion as it weighs repatriating up to $4 bil. in foreign earnings this fiscal year
Abbott Gains Sports, Weight-Loss Brands With EAS Acquisition
Abbott Laboratories' acquisition of EAS will expand the diversified firm's consumer nutritionals business, adding a number of sports nutrition bars and weight-loss products to its "healthy living" category